Brevetti EPO No.3958897 2026.05.06
Brevetti EPO
(10) Registration Number and Date
2026000425 2026.10.08
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2026/000425 2020.04.15
(40) Publication Number and Date
SM /T/2026/000425 2026.10.08
(30) Priority Details
US 201962836910 P
2019.04.22
(72) Inventor
(IT) TUTTLE, Jay Lawrence : c/o Eli Lilly and Company P.O. Box 6288, Indianapolis, Indiana 46206-6288, US
(IT) FRIEDRICH, Stuart William : c/o Eli Lilly and Company P.O. Box 6288, Indianapolis, Indiana 46206-6288, US
(IT) POLLACK, Paul Frederick : c/o Eli Lilly and Company P.O. Box 6288, Indianapolis, Indiana 46206-6288, US
(74) Representative Name
(IT) MARI, Marco Giovanni : Via Tre Settembre, 154, 47891 Dogana RSM, SM
(54) Title
(IT) MIRIKIZUMAB PER USO IN UN METODO PER TRATTARE LA MALATTIA DI CROHN
(EN) MIRIKIZUMAB FOR USE IN A METHOD OF TREATING CROHN'S DISEASE
(57) Abstract
(58) Citations